GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Relevium Technologies Inc (TSXV:RLV.H) » Definitions » EV-to-EBIT

Relevium Technologies (TSXV:RLV.H) EV-to-EBIT : -3.49 (As of Jun. 25, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Relevium Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Relevium Technologies's Enterprise Value is C$9.10 Mil. Relevium Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 was C$-2.61 Mil. Therefore, Relevium Technologies's EV-to-EBIT for today is -3.49.

The historical rank and industry rank for Relevium Technologies's EV-to-EBIT or its related term are showing as below:

TSXV:RLV.H's EV-to-EBIT is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 17.23
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Relevium Technologies's Enterprise Value for the quarter that ended in Mar. 2022 was C$7.48 Mil. Relevium Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 was C$-2.61 Mil. Relevium Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2022 was -34.91%.


Relevium Technologies EV-to-EBIT Historical Data

The historical data trend for Relevium Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relevium Technologies EV-to-EBIT Chart

Relevium Technologies Annual Data
Trend Dec12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.39 -7.37 -4.81 -1.37 -2.05

Relevium Technologies Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Mar22
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.02 -1.58 -1.20 - 8.72

Competitive Comparison of Relevium Technologies's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, Relevium Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Relevium Technologies's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Relevium Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Relevium Technologies's EV-to-EBIT falls into.



Relevium Technologies EV-to-EBIT Calculation

Relevium Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=9.102/-2.61
=-3.49

Relevium Technologies's current Enterprise Value is C$9.10 Mil.
Relevium Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Relevium Technologies  (TSXV:RLV.H) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Relevium Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2022 ) =EBIT / Enterprise Value (Q: Mar. 2022 )
=-2.61/7.47684
=-34.91 %

Relevium Technologies's Enterprise Value for the quarter that ended in Mar. 2022 was C$7.48 Mil.
Relevium Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Relevium Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Relevium Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Relevium Technologies (TSXV:RLV.H) Business Description

Traded in Other Exchanges
N/A
Address
1000 Sherbrooke Street West, Suite 2700, Montreal, QC, CAN, H3A 3G4
Relevium Technologies Inc is a Canada based company operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition, and operations of brands and businesses in the health and wellness markets including medical cannabis. Its operating segment includes Consumer Packaged Goods (CPG); Pediatric Biopharma and Corporate. The company generates maximum revenue from Consumer Packaged Goods segment.

Relevium Technologies (TSXV:RLV.H) Headlines

No Headlines